magrolimab,azacitidine
gilead sciences
['azacitidine,(-oral azaci),(-azacitidine oral)', 'mds', 'magrolimab']
today at #asco22: dr. david sallman presents phase 1b study results for magrolimab in combination with azacitidine in untreated higher-risk #myelodysplastic syndromes. #mds 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.